Archives
-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-09-03
The reference study identifies ziprasidone as a noncompetitive inhibitor of GOT1, a metabolic enzyme that supports glutamine utilization and redox balance in pancreatic ductal adenocarcinoma. Through biochemical, cellular, metabolomic, genetic, and xenograft experiments, the authors link GOT1 inhibition to impaired tumor-cell proliferation and provide a preclinical framework for studying metabolic vulnerabilities in PDAC.
-
Phosphatase Inhibitor Cocktail 1: Assay Logic
2026-09-03
Phosphatase Inhibitor Cocktail 1 helps preserve phosphorylation-dependent information before Western blotting, immunoprecipitation, and phosphoproteomic analysis. This guide focuses on assay decision-making, controls, and interpretation, using recent HPV-positive cancer research to show why pre-analytical rigor matters.
-
PDGF-BB Murine Recombinant Protein: Assay Guide
2026-09-02
PDGF-BB is a defined murine recombinant PDGF-BB mitogen for receptor-signaling and cell proliferation assays. Product specifications support controlled reconstitution, dose finding, and smooth muscle cell proliferation workflows while the latest pulmonary hypertension study provides mechanistic context rather than direct evidence of PDGF-BB treatment.
-
GSK2606414: A Practical PERK Inhibitor Workflow
2026-09-02
Use GSK2606414 as a precise perturbation tool to connect ER stress with translational control, lipid accumulation, apoptosis, and disease phenotypes. This workflow translates a TMAO-driven zebrafish liver model into practical cell-based target-engagement, rescue, and troubleshooting experiments.
-
Latrunculin B: Actin Workflow & Troubleshooting
2026-09-01
Latrunculin B enables short, controllable actin filament assembly inhibition for live-cell imaging, morphology, and cytoskeletal organization studies. Its transient, serum-sensitive activity also makes it a valuable mechanistic comparator in endocytosis and cellular actin dynamics research.
-
AP1903 for Reliable FKBP Cell Ablation
2026-09-01
This scenario-driven guide explains how AP1903 (SKU B4168) can support controlled FKBP fusion-protein activation, apoptosis pathway research, and conditional cell ablation. It connects potency data with practical choices in construct validation, solvent handling, assay controls, interpretation, and product selection.
-
Phosphatase Inhibitor Cocktail 1 for Tissue Signaling
2026-08-31
A translational framework for preserving phosphorylation-dependent information, validating tissue signaling measurements, and interpreting UPF3A biology without confusing protein abundance with post-lysis assay fidelity.
-
Tropifexor and Portal Metabolic Signaling
2026-08-31
Explore how Tropifexor (LJN452) can sharpen FXR experiments by separating receptor-driven responses from nutrient-derived portal signals. This evidence-led guide connects intestinal barrier studies, liver models, and the metabolic insights of recent triacetin research.
-
Precision Cleavage, Translational Reach
2026-08-30
PreScission Protease (PSP) turns fusion-tag removal into a strategic control point for protein quality, mechanistic interpretation, and translational reproducibility. Its HRV 3C protease specificity offers a practical route from recombinant expression to native-protein experiments, including studies of nuclear architecture such as the dKeap1–lamin Dm0 system.
-
RSV NS3 Rewires Kinase Signaling for Co-survival
2026-08-29
Zhuang et al. show that Rice stripe virus NS3 temporally redirects the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway, balancing antiviral RNA interference, reactive oxygen species, programmed cell death, and transmission. The study provides a mechanistic framework for how phosphorylation-dependent host-pathway hijacking can moderate disease severity across rice, the planthopper vector, and related host systems.
-
Betaine hydrochloride: Reliable Cell Assays
2026-08-28
Betaine hydrochloride (SKU N1700) can help researchers design more controlled biochemical and cell-based workflows when concentration, solvent, pH, and storage variables are explicitly managed. This scenario-driven guide explains compatibility testing, protocol setup, interpretation of viability data, and practical supplier-selection criteria.
-
Mc-Val-Cit-PABC-PNP: ADC Linker Workflow
2026-08-28
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for research workflows that require lysosomal payload release during antibody-drug conjugate synthesis. This guide covers solvent handling, setup, and QC while defining its limits: it is DMSO-compatible, insoluble in water and ethanol, and not intended for diagnostic, therapeutic, or aqueous applications.
-
Mc-Val-Cit-PABC-PNP ADC Linker Protocol
2026-08-27
Mc-Val-Cit-PABC-PNP is an organic-solvent-compatible peptide linker for antibody-drug conjugate workflows involving cathepsin-associated lysosomal payload release. This guide covers handling, setup, and QC while defining limits: the material is insoluble in water and ethanol, intended for research use only, and not a ready-to-use aqueous, diagnostic, or therapeutic formulation.
-
Tropifexor (LJN452) for FXR Research
2026-08-27
Tropifexor (LJN452) gives researchers a highly potent, receptor-focused way to interrogate FXR biology in intestinal barrier, liver, and metabolic models. This practical guide connects controlled FXR activation with triacetin digestion studies while emphasizing assay design, dosing, storage, and troubleshooting limits.
-
PP 2 (AG 1879): Reproducible Src Inhibition
2026-08-26
Learn how PP 2 (AG 1879), SKU A8216, can support controlled Src-family kinase perturbation in viability, proliferation, invasion, immune-signaling, and cytoskeletal assays. This scenario-based guide connects biochemical potency, solvent handling, pathway specificity, and vendor-selection criteria to practical laboratory decisions.